-
Mashup Score: 0Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common - 7 month(s) ago
IntroductionDiffuse large B cell lymphoma (DLBCL) and osteoporotic fracture are commoner in older patients (pts). Steroids and chemotherapy are recognised as a
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Introduction: Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorat
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Bone Loss & High Bone Turnover in Patients with Non-Hodgkin’s Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study - Terpos et al. #ASH19 Abstract 4124 https://t.co/94PqXvYz6h #lymsm #BoneHealth #SuppOnc #geriheme
-
-
Mashup Score: 0Webprogram Unavailable - 1 year(s) ago
61st Annual Meeting and Exposition (December 7-10, 2019) Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients’ Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era - @doctorpemm et al. #ASH19 Abstract 1670 https://t.co/ouo0ppKfcP #mpnsm
-
-
Mashup Score: 0Webprogram Unavailable - 2 year(s) ago
61st Annual Meeting and Exposition (December 7-10, 2019) Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction? - @StatlerA16 #ASH19 Abstract 381 https://t.co/FVZZoi80YQ #AMLsm #ClinicalTrials #cancerdisparities https://t.co/KaLyB7gRnq
-
-
Mashup Score: 0Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common - 2 year(s) ago
IntroductionDiffuse large B cell lymphoma (DLBCL) and osteoporotic fracture are commoner in older patients (pts). Steroids and chemotherapy are recognised as a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Fractures Common 1L R-CHOP in Older DLBCL Pts. Booth et al. @tobyeyre82 #ASH19 Abst 1615 https://t.co/BpbEXETMVi #lymsm #BoneHealth #geriheme largest series (n=477) to date to show clinically relevant fracture risk in older DLBCL pts specifically receiving R-CHOP in early f/u https://t.co/H4OPQ6PgAL
-
-
Mashup Score: 5
Introduction: Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorat
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Bone Loss & High Bone Turnover in Patients with Non-Hodgkin’s Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study - Terpos et al. #ASH19 Abstract 4124 https://t.co/94PqXvYz6h #lymsm #BoneHealth #SuppOnc #geriheme
-
-
Mashup Score: 0Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common - 2 year(s) ago
IntroductionDiffuse large B cell lymphoma (DLBCL) and osteoporotic fracture are commoner in older patients (pts). Steroids and chemotherapy are recognised as a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Fractures Common 1L R-CHOP in Older DLBCL Pts. Booth et al. @tobyeyre82 #ASH19 Abst 1615 https://t.co/BpbEXETMVi #lymsm #BoneHealth #geriheme largest series (n=477) to date to show clinically relevant fracture risk in older DLBCL pts specifically receiving R-CHOP in early f/u https://t.co/Os6s8mqZ2m
-
-
Mashup Score: 0
Introduction: Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorat
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet-
Bone Loss & High Bone Turnover in Patients with Non-Hodgkin’s Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study - Terpos et al. #ASH19 Abstract 4124 https://t.co/94PqXvYz6h #lymsm #BoneHealth #SuppOnc #geriheme
-
-
Mashup Score: 2
Introduction: Chronic immune thrombocytopenia (cITP) is a common, acquired, autoimmune disorder resulting in abnormally low blood platelet counts (<100×109/L
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Comparing the risk of complications for second-line treatments of immune thrombocytopenia in veterans: a U.S. national study - Ruiz-Negron et al. #ASH19 Abstract #85 https://t.co/wNAM2ZHNt5 #ITP https://t.co/BjaTZWH7cO
-
-
Mashup Score: 1
Leading physicians, together with patients and patient advocates, explore the potential of measurable or minimal residual disease (MRD) as a new endpoint to …
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
What is the value of #MRD testing in #multiplemyeloma & what does it mean for pts? Watch doc to hear from experts inc. @Mohty_EBMT & @MyelomaEurope 👉 https://t.co/bx5QVUgILH 👈 #mmsm #MRDdoc #ASH19 @JanssenEMEA
-
Fractures Common 1L R-CHOP in Older DLBCL Pts. Booth et al. @tobyeyre82 #ASH19 Abst 1615 https://t.co/BpbEXETMVi #lymsm #BoneHealth #geriheme largest series (n=477) to date to show clinically relevant fracture risk in older DLBCL pts specifically receiving R-CHOP in early f/u https://t.co/ehgFMfalj7